Characterization of a highly selective inhibitor of the Aurora kinases

Authors
Ferguson, Fleur M.Doctor, Zainab M.Chaikuad, ApiratSim, TaeboKim, Nam DooKnapp, StefanGray, Nathanael S.
Issue Date
2017-09-15
Publisher
Pergamon Press Ltd.
Citation
Bioorganic & Medicinal Chemistry Letters, v.27, no.18, pp.4405 - 4408
Abstract
Aurora kinases play an essential role in mitosis and cell cycle regulation. In recent years Aurora kinases have proved popular cancer targets and many inhibitors have been developed. The majority of these clinical candidates are multi-targeted, rendering them inappropriate as tools for studying Aurora kinase mediated signaling. Here we report discovery of a highly selective inhibitor of Aurora kinases A, B and C, with potent cellular activity and minimal off-target activity (PLK4). The X-ray co-crystal structure of Aurora A in complex with compound 2 is reported, and provides insights into the structural determinants of ligand binding and selectivity. (C) 2017 Elsevier Ltd. All rights reserved.
Keywords
CHROMOSOMAL PASSENGER COMPLEX; BARASERTIB AZD1152; ERK5 MAPK7; OVEREXPRESSION; ANEUPLOIDY; EFFICACY; SAFETY; CHROMOSOMAL PASSENGER COMPLEX; BARASERTIB AZD1152; ERK5 MAPK7; OVEREXPRESSION; ANEUPLOIDY; EFFICACY; SAFETY; Aurora kinase; Selective kinase inhibitor; Pan-Aurora inhibitor; Mitosis; Cancer
ISSN
0960-894X
URI
https://pubs.kist.re.kr/handle/201004/122278
DOI
10.1016/j.bmcl.2017.08.016
Appears in Collections:
KIST Article > 2017
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE